Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trialMartin Wermke, Cedrik M. Britten, Tobias A.W. Holderried et al.|Nature Medicine|2025Cited by 56
Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trialMartin Wermke, Cedrik M. Britten, Dejka M. Araujo et al.|Nature Medicine|2025Cited by 5